EX-23.1 3 mcrb-ex231_1760.htm EX-23.1 mcrb-ex231_1760.htm

Exhibit 23.1

 

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-205253) of Seres Therapeutics, Inc. of our report dated March 14, 2016 relating to the financial statements, which appears in this Form 10-K.   

 

/s/ PricewaterhouseCoopers LLP

 

Boston, Massachusetts

March 14, 2016